Characterization of light chain immunoglobulin in urine from animals and humans infected with prion diseases

Zehavit Kariv-Inbal1, Michele Halimi, Yael Dayan

  • 1Department of Neurology, The Agnes Ginges Center for Human Neurogenetics, Hadassah University Hospital, Jerusalem 91120, Israel.

Insights

Prion diseases like Creutzfeldt-Jakob disease (CJD) may be detected non-invasively through urine analysis. Researchers found specific protease-resistant proteins, including immunoglobulin light chains (LC), in the urine of CJD patients.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Infectious Diseases

Background:

  • The transmission of variant Creutzfeldt-Jakob disease (vCJD) through blood transfusions highlights the urgent need for non-invasive diagnostic tests.
  • Prion diseases are characterized by the misfolding of prion proteins, leading to neurodegeneration.

Purpose of the Study:

  • To investigate the presence of protease-resistant peptides in urine as potential biomarkers for prion diseases.
  • To determine if immunoglobulin light chains (LC) in urine can serve as indicators for Creutzfeldt-Jakob disease (CJD).

Main Methods:

  • Analysis of hamster and human urine samples using gel sequencing and immunoblotting techniques.
  • Detection of protease-resistant peptides, specifically immunoglobulin light chains (LC), in urine samples.

Main Results:

  • Urine samples from CJD patients contained an array of protease-resistant peptides.
  • Immunoglobulin light chains (LC) were identified as a component of these protease-resistant peptides in CJD patient urine.

Conclusions:

  • The presence of protease-resistant proteins, such as immunoglobulin light chains (LC), in urine suggests a potential non-invasive diagnostic marker for CJD.
  • Further research into urine analysis could lead to early detection and improved management of prion diseases.